ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,400,031 | +13.0% | 1,485,056 | -11.9% | 0.07% | -1.5% |
| Q1 2023 | $13,632,103 | -48.0% | 1,685,056 | +1.3% | 0.07% | -58.1% |
| Q4 2022 | $26,202,881 | -19.2% | 1,663,675 | -19.3% | 0.16% | -22.7% |
| Q3 2022 | $32,439,000 | +12.8% | 2,060,918 | 0.0% | 0.21% | +19.0% |
| Q2 2022 | $28,770,000 | -19.0% | 2,060,918 | 0.0% | 0.17% | -5.9% |
| Q1 2022 | $35,530,000 | +18.7% | 2,060,918 | +0.1% | 0.18% | +18.6% |
| Q4 2021 | $29,932,000 | -15.0% | 2,058,618 | +5.3% | 0.16% | -18.3% |
| Q3 2021 | $35,201,000 | +43.4% | 1,955,605 | +39.8% | 0.19% | +37.4% |
| Q2 2021 | $24,555,000 | +85.3% | 1,398,372 | +165.9% | 0.14% | +67.5% |
| Q1 2021 | $13,252,000 | – | 525,863 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |